Drug firm Hetero on Wednesday said it has launched generic oral antiviral drug Favipiravir used for the treatment of patients with mild to moderate COVID-19, in India under the brand name 'Favivir'......
Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......